miRNA-486-5p: signaling targets and role in non-malignant disease

Adrianna Douvris1,2, Jose Viñas1, Kevin D Burns3,4

  • 1Division of Nephrology, Department of Medicine and Kidney Research Centre, The Ottawa Hospital Research Institute, University of Ottawa, 1967 Riverside Dr., Rm. 535, Ottawa, ON, K1H 7W9, Canada.

Insights

MicroRNAs (miRNAs), like miR-486-5p, regulate gene expression and are implicated in disease. This review explores miR-486-5p

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Background:

  • MicroRNAs (miRNAs) are key regulators of gene expression, with aberrant levels linked to human diseases.
  • miR-486-5p, a muscle-enriched miRNA, is abundant in plasma and extracellular vesicles, showing potential as a disease biomarker.
  • Its dysregulation is observed in various conditions, including kidney diseases.

Purpose of the Study:

  • To review the biogenesis and regulation of miR-486-5p.
  • To identify and discuss validated gene targets of miR-486-5p.
  • To examine the biological effects of miR-486-5p in non-malignant diseases.

Main Methods:

  • Literature review of pre-clinical and clinical studies.
  • Analysis of miRNA biogenesis and regulatory mechanisms.
  • Identification and validation of miR-486-5p gene targets and their associated signaling pathways.

Main Results:

  • miR-486-5p targets include PTEN, FoXO1, Smad1/2/4, IGF-1, MMP-19, Sp5, HAT1, and NFAT5.
  • Suppression of PTEN and FoXO1 by miR-486-5p activates PI3K/Akt signaling.
  • Inhibition of TGF-β and IGF-1 signaling by miR-486-5p targeting Smad1/2/4 and IGF-1, respectively.

Conclusions:

  • miR-486-5p plays a significant role in regulating cellular processes like proliferation, migration, angiogenesis, and apoptosis.
  • Validated targets of miR-486-5p provide insights into its function in non-malignant diseases.
  • Further research into miR-486-5p's biological effects can enhance its potential as a diagnostic and therapeutic target.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.9K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.4K